NCT07256496 is a NA clinical trial of Enhanced DBT-A in Suicidality, sponsored by Compass Behavioral Health.

Who is sponsoring NCT07256496?

NCT07256496 is sponsored by Compass Behavioral Health.

What drugs are being tested in NCT07256496?

Interventions in NCT07256496: Enhanced DBT-A.

What condition does NCT07256496 study?

NCT07256496 studies Suicidality.

Is NCT07256496 still recruiting?

NCT07256496 is currently completed. Last updated 1 December 2025.

Last reviewed 2025-12-01 · How we verify

NCT07256496

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enhanced Dialectical Behavior Therapy for Adolescents

Completed NA Last updated 1 December 2025

What this trial tests

NA trial testing Enhanced DBT-A in Suicidality in 47 participants. Completed in 26 August 2022.

Timeline

17 October 2014

Primary endpoint
26 August 2022

26 August 2022

Quick facts

Lead sponsor	Compass Behavioral Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	47
Start date	17 October 2014
Primary completion	26 August 2022
Estimated completion	26 August 2022
Sites	1 location across United States

Drugs / interventions tested

Enhanced DBT-A

Conditions studied

Suicidality — all drugs for Suicidality →

Sponsor

Compass Behavioral Health

Who can join

Adults 13 to 25, any sex, with Suicidality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Suicide is a leading cause of death and significant concerns for adolescents and young adults. Dialectical Behavior Therapy for Adolescents (DBT-A) is an evidence-based intervention that effectively reduces life-threatening behaviors. Limited research examines the impact of adding individualized skills coaching sessions (ISCS) to the DBT-A model, a novel intervention referred to in this paper as "Enhanced DBT-A". This study evaluates the effectiveness of Enhanced DBT-A in reducing suicidality over 1 year of treatment in an outpatient and intensive outpatient setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Suicidality

Currently open trials in the same condition.

NCT06636357 — Nitrous Oxide in the Treatment of Acute Suicidal Ideation · Phase 2 · recruiting
NCT04197765 — acTBS Treatment for Inpatient Subjects With Suicidality · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07256496 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Compass Behavioral Health
Last refreshed: 1 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07256496.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing